Publications

Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET Ventura D, Rassek P, Schindler P, Akkurt BH, Bredensteiner L, Bögemann M, Schlack K, Seifert R, Schäfers M, Roll W, Rahbar K (2024) In: Cancer Imaging, 18(24(1)), 126. doi:10.1186/s40644-024-00773-w Research article (journal) \| Peer reviewed \| Published
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017) In: ((Bitte Journal prüfen)), 18. Research article (journal) \| Peer reviewed \| Published
The safety and efficacy of gemcitabine for the treatment of bladder cancer Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) In: ((Bitte Journal prüfen)), 16(3). Research article (journal) \| Peer reviewed \| Published
The role of fPSA, [-2]proPSA and the Prostate Health Index for the early prediction of outcome in patients with metastatic castration resistant prostate cancer on therapy with abirateroneacetate. Schlack K, Krabbe LM, Eminaga O, Semjonow A, Boegemann M (2016) In: ASCO-GU, San Francisco. Abstract in digital collection (conference) \| Published
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate Boegemann M, Schlack K, Fischer AK, Gerß J, Steinestel J, Semjonow A, Schrader AJ, Krabbe LM (2016) In: PloS one, 11. Research article (journal) \| Peer reviewed \| Published

Show all publications (7)

Prizes

Paul-Mellin-Gedächtnispreis 2026
Awarded by: Nordrhein-Westfälische Gesellschaft für Urologie
Award given to: Seifert, Konstantin Egon; Schlack, Katrin; Büther, Florian; Landau, Felicitas; Breyholz, Hans-Jörg; Rust, Martin; Schindler, Philipp; Rahbar, Kambiz; Bögemann, Martin
Announced at: 16/04/2026 | Date of awarding: 16/04/2026
Type of distinction: Best presentation award

Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET Ventura D, Rassek P, Schindler P, Akkurt BH, Bredensteiner L, Bögemann M, Schlack K, Seifert R, Schäfers M, Roll W, Rahbar K (2024) In: Cancer Imaging, 18(24(1)), 126. doi:10.1186/s40644-024-00773-w Research article (journal) \| Peer reviewed \| Published
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017) In: ((Bitte Journal prüfen)), 18. Research article (journal) \| Peer reviewed \| Published
The safety and efficacy of gemcitabine for the treatment of bladder cancer Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) In: ((Bitte Journal prüfen)), 16(3). Research article (journal) \| Peer reviewed \| Published
The role of fPSA, [-2]proPSA and the Prostate Health Index for the early prediction of outcome in patients with metastatic castration resistant prostate cancer on therapy with abirateroneacetate. Schlack K, Krabbe LM, Eminaga O, Semjonow A, Boegemann M (2016) In: ASCO-GU, San Francisco. Abstract in digital collection (conference) \| Published
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate Boegemann M, Schlack K, Fischer AK, Gerß J, Steinestel J, Semjonow A, Schrader AJ, Krabbe LM (2016) In: PloS one, 11. Research article (journal) \| Peer reviewed \| Published

Katrin Schlack

Current affiliations

Publications

Prizes

Operated by

Top-Links